CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
1000CsK Silicon Oil Tamponadeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01460810
NCT01460810N/ACompleted
CompareCT.gov

A Prospective Pilot Study of Surgical Radiation Shielding With Vitrectomy & Silicone Oil Tamponade for the Protection of Radiation-induced Ocular Injury in the Treatment of Choroidal Melanoma With Radioactive Iodine-125 Plaque Brachytherapy

University of Colorado, Denver·interventional·Posted Oct 27, 2011·Updated Mar 7, 2022

In Brief

A clinical study evaluating 1000CsK Silicon Oil Tamponade for Choroidal Melanoma. Completed, enrolled 20 participants across 1 site.

Detailed Summary

A prospective, experimental, case series of 20 patients, with choroidal melanoma, in which pars plana vitrectomy and Silicone oil as vitreous substitute will be used as intraocular shielding for attenuating the deleterious effects of radiation dose delivered to healthy ocular tissue during Iodine-125 plaque brachytherapy treatment and assess if the treatment can reduce the incidence and severity of radiation-induced adverse effects like radiation retinopathy and permanent loss of vision.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChoroidal Melanoma
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 27, 2011
Enrollment StartJul 1, 2011
Primary CompletionMay 4, 2021
TodayJul 2, 2026
Enrollment to primary: 9.8 yearsPosted 14.7 years ago

Interventions

1000CsK Silicon Oil Tamponadeother

Details covered in arm description